{"pageContent": "The treatment of prostate cancer with remote metastases has advanced greatly in recent years. Treatment options are dependent on the extent of the metastases, the patient\u2019s general condition and wishes, and the treatment response. We present an overview of the latest options for systemic treatment of patients with metastatic prostate cancer, based on availability in Norway.", "metaData": {"source": "A review of high-risk prostate cancer and the role of neo-adjuvant and adjuvant therapies\nhttps://pubmed.ncbi.nlm.nih.gov/18762948/"}}